s, 2H, CH 2 ), 3.66 (s, 3H, NMe Phthal ), 3.54 (s, 3H, NMe, ), 2.29 (t, J = 7.5 Hz, 2H, CH 2 CO) 13 C NMR (100 MHz, DMSO-d 6 ) ? 171.5 (CONH) IV ), 152.5 (C IV-C=N ), pp.28-32 ,
8 Hz, 2H, 2 x H ar ), 4.50 (s, 2H (s, 3H, NMe Phthal ), 3.56 (s, 3H, NMe), 3.15 (t, 2H, SCH 2 ) 2H, CH 2 CO), p.7830 ,
CH ar )133.4 (CH ar-Phthal ) ,
HRMS (MALDI: DHB, PEG 600): calcd ,
71 (m, 2H, 2 x H ar-Phthal ), 7.41 (d, J = 9, 79 (d, J = 9.0 Hz, 2H, 2 x H ar ), 4.46 (s, 2H, pp.80-87 ,
21 (m, 1H, H ar-Phthal ), 7.75 (m, 2H, 2 x H ar-Phthal ), 77.65 (bs, 3.79 (s, 3H, NMe Phthal ), 3.53 (s, 3H, NMe), 3.17 (t, J = 7.3 Hz, 2H, SCH 2 ), 2.41 (t, J = 7.4 Hz, 2H, CH 2 CO), 1.70 (m, 4H, 2 x CH 2 ), 1.32 (m, 12H, 6 x CH 2 ). 13 C NMR (75 MHz, CDCl 3 ) ? 171, p.35 ,
CDCl 3 ) ? 171, pp.140-148 ,
57 (m, 3H, 2 x H ar-Phthal and H ar, pp.86-736 ,
49 (s, 2H, CH 2 ), 3.82 (s, 3H, NMe Phthal ), 3.19 (t, ), 2.41 (t, J = 7.4 Hz, 2H, CH 2 CO), 1.79-1.69 (m, 4H, 2 x CH 2 13 C NMR (100 MHz, CDCl 3 ) ? 171.3 (CONH), pp.62-92 ,
Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor, Science, vol.264, issue.2, pp.965-968, 1994. ,
A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells, Proc. Natl. Acad. Sci. U ,
Increased numbers of interleukin-15-expressing cells in active ulcerative colitis, Am. J. Gastroenterol. Ruckert, R.; Asadullah, K.; Seifert, M.; Budagian, V. M. C, vol.91, issue.914, pp.4935-4939, 1994. ,
Inhibition of keratinocyte apoptosis by IL-15: a new parameter in the pathogenesis of psoriasis?, J. Immunol, vol.165, pp.2240-2250, 2000. ,
Interleukin 15: a proinflammatory role in rheumatoid arthritis synovitis, Immunol. Today Pavlakis, M.; Strehlau, J.; Lipman, M, vol.35, issue.197, pp.37-45, 1998. ,
Intragraft IL-15 transcripts are increased in human renal allograft rejection, Transplantation, vol.62, issue.8, pp.543-545, 1996. ,
Interleukin-15 gene transcripts are present in rejecting islet allografts, Liew, F. Y. Soluble IL-15, pp.1077-1078, 1997. ,
Targeting IL-15 receptorbearing cells with an antagonist mutant IL-15/Fc protein prevents disease development and progression in murine collagen-induced arthritis Interleukin-15 receptor-directed immunotoxins atteunuate disease severity in rat adjuvant arthritis, J. Immunol. Mol. Immunol, vol.173, issue.4712, pp.5818-5826, 2004. ,
Therapeutic potential of IL-15 in rheumatoid arthritis ,
State-of-the-art strategies for targeting protein?protein interactions by small-molecule inhibitors, Chem. Soc. Rev., vol.6, issue.22, pp.812-818, 2015. ,
DOI : 10.1371/journal.pcbi.1000695
Drug-Like Protein-Protein Interaction Modulators: Challenges and Opportunities for Drug Discovery and Chemical Biology, Mol. Inform. M, vol.2014, issue.3315, pp.414-437 ,
Integrating fragment assembly and biophysical methods in the chemical advancement of small-molecule antagonists of IL-2: an approach for inhibiting protein-protein interactions In vitro and in silico exploration of IL-2 inhibition by small drug-like molecules Systemic delivery of small interfering RNA targeting the interleukin-2/15 receptor ? chain prevents disease progression in experimental arthritis Structure-function studies of interleukin 15 using site-specific mutagenesis, polyethylene glycol conjugation, and homology modeling, J. Med. Chem. Med. Chem. Res. PLoS One J. Biol. Chem. J. C E, vol.47, issue.272, pp.3111-3130, 1997. ,
Common gamma chain cytokines in combinatorial immune strategies against cancer, Immunology Letters, vol.169, issue.169, pp.24313-24322, 2004. ,
DOI : 10.1016/j.imlet.2015.11.007
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710466
Crystal structure of the IL-15-IL-15R? complex, a cytokine-receptor unit presented in trans, Nat. Immunol. N, vol.8, issue.22, pp.1001-1007, 2007. ,
mutein exhibits potent antitumor activity and is well tolerated in vivo, Nat. Biotechnol, vol.18, issue.223, pp.1197-1202, 2000. ,
Identification of specific residues of human interleukin 2 ,
Structure of the quaternary complex of interleukin-2 with its ?, ?, and ?c receptors, Science, vol.85, issue.31025, pp.7709-7713, 1988. ,
Mechanistic and structural insight into the functional dichotomy between IL-2 and IL-15, Nat. Immunol. J, vol.13, issue.26, pp.1187-1195, 2012. ,
Soluble interleukin-15 receptor ? (IL-15R?)-sushi as a selective and potent agonist of IL-15 action through IL-15R?/?. Hyperagonist IL-15 x IL-15R? fusion proteins, J ,
Alkylsulfanyl-1,2,4-triazoles, a new class of allosteric valosine containing protein inhibitors. Synthesis and structure-activity relationships, 29) Carpino, L. A.; El-Faham, pp.437-450, 2013. ,
Synthesis and antimicrobial activity of 2-substituted [4- (1,3,4-oxadiazol-2-yl methyl)] phthalazin-1(2H)-one derivatives Synthesis, characterization and preliminary anticonvulsant evaluation of some 4-alkyl-1, 34) Sridhara, A. M.; Venugopala, K. R.; Keshavayya, pp.1004-1007, 2010. ,
Synthesis and antimicrobial studies of some new 3-isoxazoline substituted phthalazine methylsulfonyl oxadiazoles, E-Journal of Chemistry, vol.8, pp.1022-1029, 2011. ,
The chemistry of mercapto-and thione-substituted 1,2,4-triazoles and their utility in heterocyclic synthesis The growing impact of click chemistry on drug discovery, ARKIVOC Drug Discovery Today, vol.8, issue.36, pp.59-112, 2003. ,
A Stepwise Huisgen Cycloaddition Process: Copper(I)-Catalyzed Regioselective ???Ligation??? of Azides and Terminal Alkynes, Angewandte Chemie International Edition, vol.20, issue.14, pp.2596-2599, 2002. ,
DOI : 10.1016/0040-4039(95)00987-N
Tumor targeting of the IL-15 superagonist RLI by an anti-GD2 antibody strongly enhances its antitumor potency, International Journal of Cancer, vol.11, issue.3, pp.757-765, 2013. ,
DOI : 10.1158/1535-7163.MCT-12-0019
targeting established human B lymphoma in SCID mouse, MAbs, vol.6, issue.40, pp.1026-1037, 2014. ,
Identification of a small molecule inhibitor of the IL-2/IL- 2R? receptor interaction which binds to IL-2 The synthesis and selective IL-2 inhibitory activity of bis piperazine-phenol Mannich adducts, 42) Waldmann, T. A. Targeting the interleukin-15/interleukin-15 receptor system in inflammatory autoimmune diseases, pp.7589-7590, 1997. ,
Targeting the interleukin-15 system in rheumatoid arthritis Arthritis Rheum, C, vol.52, issue.43, pp.2585-2588, 2005. ,
Humanized antibody directed to the IL-2 receptor beta-chain prolongs primate cardiac allograft survival, J. Immunol. N, vol.153, issue.45, pp.4330-4338, 1994. ,
Targeting the binding interface on a shared receptor subunit of a cytokine family enables the inhibition of multiple member cytokines with selectable target spectrum, J. Biol ,
Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: conformationally flexible docking by evolutionary programming (48) Muegge, I.; Martin, Y. C. A general and fast scoring function for protein-ligand interactions: a simplified potential approach LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays, LigScore: a novel scoring function for predicting binding affinities, pp.395-407, 1995. ,